123 related articles for article (PubMed ID: 11502772)
21. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
22. [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
Baranauskas ZL; Mamontov VV; Valutskas KK
Med Radiol (Mosk); 1989 Oct; 34(10):31-4. PubMed ID: 2811625
[TBL] [Abstract][Full Text] [Related]
23. Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy.
Vera L; Gay S; Campomenosi C; Paolino S; Pera G; Monti E; Mortara L; Seriolo B; Giusti M
Endokrynol Pol; 2016; 67(4):350-8. PubMed ID: 27387240
[TBL] [Abstract][Full Text] [Related]
24. [Bone tissue mineral density in patients with thyroid gland cancer on levothyroxine natrium therapy].
Khmara IM; Tolkachev IuV
Klin Med (Mosk); 2005; 83(10):61-5. PubMed ID: 16320850
[TBL] [Abstract][Full Text] [Related]
25. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
Elisei R; Schlumberger M; Driedger A; Reiners C; Kloos RT; Sherman SI; Haugen B; Corone C; Molinaro E; Grasso L; Leboulleux S; Rachinsky I; Luster M; Lassmann M; Busaidy NL; Wahl RL; Pacini F; Cho SY; Magner J; Pinchera A; Ladenson PW
J Clin Endocrinol Metab; 2009 Nov; 94(11):4171-9. PubMed ID: 19850694
[TBL] [Abstract][Full Text] [Related]
26. Circulating 131I thyroxine and thyroid cancer.
Hays MT; McDougall IR
Thyroid; 1994; 4(2):195-8. PubMed ID: 7920003
[TBL] [Abstract][Full Text] [Related]
27. [Age of menopause in patients with differentiated thyroid cancer treated with radioiodine].
Manuel García-Quirós Muñoz J; Martín Hernández T; Torres Cuadro A; Cambil Molina T; Castro Montaño J; Sendón Pérez A
Endocrinol Nutr; 2010 Mar; 57(3):105-9. PubMed ID: 20304710
[TBL] [Abstract][Full Text] [Related]
28. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of effects of L-thyroxine therapy in differentiated thyroid carcinoma on the cardiovascular system --prospective study].
Matuszewska G; Roskosz J; Włoch J; Jurecka-Tuleja B; Hasse-Lazar K; Kowalczyk P; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():373-7. PubMed ID: 12182052
[TBL] [Abstract][Full Text] [Related]
30. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
31. Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer.
Serhal DI; Nasrallah MP; Arafah BM
J Clin Endocrinol Metab; 2004 Jul; 89(7):3285-9. PubMed ID: 15240604
[TBL] [Abstract][Full Text] [Related]
32. Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma.
Koong SS; Reynolds JC; Movius EG; Keenan AM; Ain KB; Lakshmanan MC; Robbins J
J Clin Endocrinol Metab; 1999 Mar; 84(3):912-6. PubMed ID: 10084570
[TBL] [Abstract][Full Text] [Related]
33. Differentiated thyroid cancer: lobectomy and radioiodine, a treatment suitable for all cases?
Allan E; Owens SE; Waller ML
Nucl Med Commun; 1999 Nov; 20(11):983-9. PubMed ID: 10572907
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
35. Bone mineral density in treated at a young age for differentiated thyroid cancer after Chernobyl female patients on TSH-suppressive therapy receiving or not Calcium-D3 supplementation.
Leonova TA; Drozd VM; Saenko VA; Mine M; Biko J; Rogounovitch TI; Takamura N; Reiners C; Yamashita S
Endocr J; 2015; 62(2):173-82. PubMed ID: 25374130
[TBL] [Abstract][Full Text] [Related]
36. [Therapy of differentiated thyroid carcinomas. Prospective study].
Gemsenjäger E; Staub JJ; Heitz PU
Schweiz Med Wochenschr; 1985 Feb; 115(5):153-9. PubMed ID: 3975583
[TBL] [Abstract][Full Text] [Related]
37. Radioactive iodine in the treatment of medullary carcinoma of the thyroid.
Saad MF; Guido JJ; Samaan NA
J Clin Endocrinol Metab; 1983 Jul; 57(1):124-8. PubMed ID: 6853671
[TBL] [Abstract][Full Text] [Related]
38. [The importance of bisoprolol in prevention of heart left ventricular hypertrophy in patients with long term L-thyroxin suppressive therapy, after the operation of differentiated thyroid carcinoma].
Matuszewska G; Marek B; Kajdaniuk D; Przywara-Chowaniec B; Jarzab J; Jarzab B
Endokrynol Pol; 2007; 58(5):384-96. PubMed ID: 18058733
[TBL] [Abstract][Full Text] [Related]
39. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients.
Schlumberger M; De Vathaire F; Ceccarelli C; Delisle MJ; Francese C; Couette JE; Pinchera A; Parmentier C
J Nucl Med; 1996 Apr; 37(4):606-12. PubMed ID: 8691249
[TBL] [Abstract][Full Text] [Related]
40. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.
Costante G; Crocetti U; Schifino E; Ludovico O; Capula C; Nicotera M; Arturi F; Filetti S
J Endocrinol Invest; 2004 Jan; 27(1):31-6. PubMed ID: 15053240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
